Literature DB >> 9330846

Chemical warfare. Nerve agent poisoning.

C P Holstege1, M Kirk, F R Sidell.   

Abstract

The threat of civilian and military casualties from nerve agent exposure has become a greater concern over the past decade. After rapidly assessing that a nerve agent attack has occurred, emphasis must be placed on decontamination and protection of both rescuers and medical personnel from exposure. The medical system can become rapidly overwhelmed and strong emotional reactions can confuse the clinical picture. Initially, care should first be focused on supportive care, with emphasis toward aggressive airway maintenance and decontamination. Atropine should be titrated, with the goal of therapy being drying of secretions and the resolution of bronchoconstriction and bradycardia. Early administration of pralidoxime chloride maximizes antidotal efficacy. Benzodiazepines, in addition to atropine, should be administered if seizures develop. Early, aggressive medical therapy is the key to prevention of the morbidity and mortality associated with nerve agent poisoning.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9330846     DOI: 10.1016/s0749-0704(05)70374-2

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  17 in total

Review 1.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

2.  Cholinergic neurotransmission in the preBötzinger Complex modulates excitability of inspiratory neurons and regulates respiratory rhythm.

Authors:  X M Shao; J L Feldman
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Effects of repeated low-dose exposure of the nerve agent VX on monoamine levels in different brain structures in mice.

Authors:  S Graziani; D Christin; S Daulon; P Breton; N Perrier; L Taysse
Journal:  Neurochem Res       Date:  2014-03-28       Impact factor: 3.996

Review 4.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

5.  Engineering Dynamic Surface Peptide Networks on ButyrylcholinesteraseG117H for Enhanced Organophosphosphorus Anticholinesterase Catalysis.

Authors:  Kirstin P Hester; Krishna Bhattarai; Haobo Jiang; Pratul K Agarwal; Carey Pope
Journal:  Chem Res Toxicol       Date:  2019-08-28       Impact factor: 3.739

6.  Novel Organophosphate Ligand O-(2-Fluoroethyl)-O-(p-Nitrophenyl)Methylphosphonate: Synthesis, Hydrolytic Stability and Analysis of the Inhibition and Reactivation of Cholinesterases.

Authors:  Chih-Kai Chao; S Kaleem Ahmed; John M Gerdes; Charles M Thompson
Journal:  Chem Res Toxicol       Date:  2016-10-17       Impact factor: 3.739

7.  Rapid quantification of two chemical nerve agent metabolites in serum.

Authors:  Michael Kammer; Amanda Kussrow; Melissa D Carter; Samantha L Isenberg; Rudolph C Johnson; Robert H Batchelor; George W Jackson; Darryl J Bornhop
Journal:  Biosens Bioelectron       Date:  2019-01-31       Impact factor: 10.618

8.  Inhalation of the nerve gas sarin impairs ventilatory responses to hypercapnia and hypoxia in rats.

Authors:  Jianguo Zhuang; Fadi Xu; Matthew J Campen; Cancan Zhang; Juan C Pena-Philippides; Mohan L Sopori
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-28       Impact factor: 4.219

9.  Intramuscular ophthalmic homatropine vs. atropine to prevent lethality in rates with dichlorvos poisoning.

Authors:  Sean M Bryant; Brandon K Wills; James W Rhee; Steven E Aks; Gerald Maloney
Journal:  J Med Toxicol       Date:  2006-12

10.  Aging mechanism of soman inhibited acetylcholinesterase.

Authors:  Gulseher Sarah Sirin; Yanzi Zhou; Lee Lior-Hoffmann; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2012-09-28       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.